Guardant Health is a leading precision oncology company that combines proprietary blood tests with vast data sets and advanced analytics.  Its Guardant Health Oncology Platform is designed improve clinical outcomes and lower healthcare costs.  In pursuit of its goal to manage cancer across all stages of the disease, Guardant Health has launched multiple liquid biopsy-based tests for advanced stage cancer patients which fuel its development programs for recurrence and early detection.  NASDAQ:GH